Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction.

Literature DB >> 27852682

Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction.

Adam Baghban¹, Marwan Mikheal Azar², Raffaele Mario Bernardo¹, Maricar Malinis^1,3.

Abstract

Mycobacterium tuberculosis presents unique challenges in the peritransplant period. Here, we describe a case of disseminated tuberculosis following renal transplantation with alemtuzumab induction immunosuppression in a patient with remotely treated pulmonary tuberculosis and ongoing risk factors for re-infection. We also review the available literature regarding the prevalence of tuberculosis infection following solid organ transplant and management of high-risk patients, including the role for isoniazid preventative therapy. 2016 BMJ Publishing Group Ltd.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2016 PMID： 27852682 PMCID： PMC5129162 DOI： 10.1136/bcr-2016-217998

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

27 in total

1. Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group.

Authors: Seok Jin Kim; Joon Ho Moon; Hawk Kim; Jin Seok Kim; Yu Yan Hwang; Tanin Intragumtornchai; Surapol Issaragrisil; Jae Yong Kwak; Je Jung Lee; Jong Ho Won; Arry Harryanto Reksodiputro; Soon Thye Lim; Ann-Lii Cheng; Won Seog Kim; Yok Lam Kwong
Journal: Leuk Lymphoma Date: 2012-03-01

Review 2. Mycobacterium tuberculosis infection in recipients of solid organ transplants.

Authors: Patricia Muñoz; Claudia Rodríguez; Emilio Bouza
Journal: Clin Infect Dis Date: 2005-01-25 Impact factor: 9.079

3. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.

Authors: Anton Y Peleg; Shahid Husain; Eun J Kwak; Fernanda P Silveira; Magdaline Ndirangu; Jerry Tran; Kathleen A Shutt; Ron Shapiro; Ngoc Thai; Kareem Abu-Elmagd; Kenneth R McCurry; Amadeo Marcos; David L Paterson
Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079

Review 4. Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies.

Authors: Vicki A Morrison
Journal: Clin Infect Dis Date: 2014-11-15 Impact factor: 9.079

5. Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis-burden country.

Authors: Su Jin Jeong; Sang Hoon Han; Chang Oh Kim; Ji-Hyeon Baek; Sung Joon Jin; Nam Su Ku; Jun Yong Choi; Young Goo Song; Hyon-Suk Kim; June Myung Kim
Journal: J Infect Date: 2011-03-15 Impact factor: 6.072

6. Risk factors for post-transplant tuberculosis.

Authors: G T John; V Shankar; A M Abraham; U Mukundan; P P Thomas; C K Jacob
Journal: Kidney Int Date: 2001-09 Impact factor: 10.612

7. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors: Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245

Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction.

1. Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group.

Review 2. Mycobacterium tuberculosis infection in recipients of solid organ transplants.

3. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.

Review 4. Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies.

5. Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis-burden country.

6. Risk factors for post-transplant tuberculosis.

7. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

8. Tuberculous infection in southern Chinese renal transplant recipients.

9. Tuberculosis in southern Chinese renal-transplant recipients.

10. Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

Review 1. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Review 2. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients.